Clinical trials
Gastrointestinal Neoplasms trials in Turkey (Türkiye)
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
21 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2019 | 1 |
| 2020 | 3 |
| 2021 | 3 |
| 2022 | 2 |
| 2023 | 1 |
| 2024 | 3 |
| 2025 | 4 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 14 |
| Recruiting | 3 |
| Active, not recruiting | 2 |
| Approved for marketing | 1 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Ankara Etlik City Hospital | 3 |
| Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital | 3 |
| Van Training and Research Hospital | 2 |
| Amgen | 1 |
| Ankara Oncology Research and Training Hospital | 1 |
| Artvin Coruh University | 1 |
| AstraZeneca | 1 |
| Ataturk University | 1 |
| Cumhuriyet University | 1 |
| Dr. Lutfi Kirdar Kartal Training and Research Hospital | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Gastrointestinal Neoplasms | 21 |
| Sarcopenia | 4 |
| Colorectal Neoplasms | 3 |
| Frailty | 3 |
| Malnutrition | 2 |
| Pancreatic Neoplasms | 2 |
| Postoperative Complications | 2 |
| Sleep Initiation and Maintenance Disorders | 2 |
| Stomach Neoplasms | 2 |
| Appendicitis | 1 |
Trials
Showing 26 to 21 of 21. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.